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htcense.Abstract Schistosmiasis has long been an endemic disease in Egypt and an important cause of pul-
monary hypertension.
Objectives: We aimed to investigate the clinical and polysomnographic features of sleep-related
breathing disorders (SRBD) in patients with schistosomal cor-pulmonale and to evaluate their
effects on pulmonary hemodynamics.
Patients and methods: We studied 10 stable patients diagnosed with schistosomal pulmonary
hypertension (7 males and 3 females their mean age was 43.7 ± 8.04) and 10 healthy volunteers
matched for age, sex and BMI. Patients’ exclusion criteria were: smoking, morbid obesity, other sec-
ondary causes of pulmonary hypertension, systemic hypertension, ischemic or rheumatic heart dis-
ease or left heart failure. All patients underwent overnight polysomnography or ambulatory
cardiorespiratory sleep studies, spirometry, ECG and echocardiography. Daytime sleepiness was
also assessed using the Epworth sleepiness scale (ESS).
Results: The mean AHI in patients group was 20.0 ± 11.34/h while in the control group it was
2.3 ± 1.16/h. 80% of the patients were found to have an AHI > 10/h and 60% had moderate to
severe sleep apnea (AHIP 15/h). In addition, the majority of the patients (80%) spent > 30%
of the night with an arterial oxygen saturation <90%. SRBD were not correlated with anthropo-
metric measures, spirometry nor with the typical symptoms of SA such as excessive sleepiness as
assessed by ESS. More importantly, SRBD were signiﬁcantly associated with measures of pulmon-
ary hypertension severity, and patients with moderate to severe SA had more impaired cardiovas-hest Medicine Department,
andria University, Alazarita
1228030936.
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204 Y. Khalil et al.cular function as indicated by more severe right ventricular dilatation (p= 0.036) than patients
with mild sleep apnea.
Conclusion: SRBD are highly prevalent in patients with schistosomal pulmonary hypertension
(PH). Also, the SA severity was correlated with more advanced PH and more severe cardiovascular
impairment. Therefore in the evaluation of patients with schistosomal PH, polysomnography or an
ambulatory cardiorespiratory sleep study seems justiﬁed to identify potentially treatable SRBD that
may additionally challenge the already compromised cardiovascular system in these patients.
ª 2012 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
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Pulmonary hypertension (PHT) is a serious clinical condition
which has a very high morbidity and mortality. If untreated,
its 50% survival is less than two years, making its prognosis
similar to some cancers and other lethal clinical conditions
[1]. Pulmonary hypertension can be idiopathic or secondary
to other diseases like congenital heart disease, connective tissue
diseases, HIV infection, liver cirrhosis, sickle cell anemia,
chronic thromboembolic disease, and primary lung disease [2].
More than 35 million people in the developing world may
suffer from pulmonary hypertension, mainly because of predis-
position to pre-existing infectious conditions (e.g., schistosomi-
asis and HIV), chronic obstructive lung diseases, and high
altitude. Schistosomiasis (Bilharzia) is the third leading ende-
mic parasitic disease in the world, following malaria and amoe-
biasis. 200 million people are estimated to be infected with
schistosomiasis worldwide, this will make schistosomiasis the
most common cause of pulmonary hypertension worldwide
[3]. Its importance might be even greater in endemic regions
for schistosomiasis. Indeed, it is estimated that up to 30% of
all pulmonary hypertension patients followed at reference cen-
ters in Brazil have Sch-PAH [4]. In the updated classiﬁcation
of PAH, following the better understanding of the mechanisms
involved in Sch-PAH as well as its hemodynamic features, Sch-
PAH, which was previously subcategorized in Group 4, has
been reclassiﬁed within group 1 (PAH), the group that gener-
ates the biggest interest in the area, as well as the most re-
searched of all ﬁve groups [5].
Sleep disordered breathing (SDB) is a term that encom-
passes the spectrum of sleep-related breathing disorders that
include central and obstructive sleep apnea (OSA) and noctur-
nal desaturations [6]. Sleep-related breathing disorders and
pulmonary hypertension (PH) are inextricably linked,
although the mechanisms of association are complex. Physio-
logic changes associated with sleep-related breathing disorders,
including hypoxia, hypercoagulability, and systemic inﬂamma-
tion, may result in alterations in pulmonary hemodynamic [7].
While SDB is known to cause pulmonary hypertension, the
prevalence of SDB among patients with pulmonary hyperten-
sion is not known [8].
Cheyne–Stokes respiration (CRS) and central sleep apnea
(CSA) are highly prevalent in patients with severe congestive
left ventricular heart failure and are associated with progres-
sion of heart failure, poor quality of life, and reduced survival.
However, little is known about breathing disorders in patients
with right ventricular dysfunction associated with pulmonary
hypertension [9].
Whether SDB occurs as a consequence of PH or SDB in-
duces PH has not yet been clariﬁed. Schistosomiasis-associatedpulmonary arterial hypertension (Sch-PAH) may be one of the
most prevalent forms of pulmonary arterial hypertension
(PAH) worldwide, and yet the least studied disease in the tro-
pics, making this disease a really ‘‘forgotten disease’’ [3].
Schistosmiasis has long been an endemic disease in Egypt
and an important cause of pulmonary hypertension. Therefore
we chose to investigate the clinical and polysomnographic fea-
tures of sleep-related breathing disorders (SRBD) in patients
with schistosomal cor-pulmonale and to evaluate their effects
on pulmonary hemodynamics.
Patients and methods
Ten stable patients diagnosed with schistosomal pulmonary
hypertension (7 males and 3 females) and 10 healthy volunteers
matched for age, sex and BMI were enrolled in this study.
They were admitted to Alexandria University Hospitals, Alex-
andria, Egypt. All patients were enrolled in the study after a
written informed consent according to a protocol approved
by the Ethics Committee of the Alexandria Main University
Hospital (Faculty of Medicine).
Inclusion criteria were:
 Pulmonary hypertension with mean PAP greater than
20 mm Hg at rest.
 Schistosomal cor-pulmonale as diagnosed by previous
history of schistosomal affection and by
echocardiography.
 Stable and ambulatory patients (on same treatment for
at least 4 weeks).
 Indirect haemagglutination test for schistosomal anti-
body is positive.
 Normal left vertricular ejection fraction.
Exclusion criteria were:
 A body mass index more than 35 kg/m2.
 Smoking.
 Systemic hypertension, ischemic or rheumatic heart
disease.
 Other causes of secondary pulmonary hypertension as:
collagenic, congenital, or chronic thromboembolic.
 Liver, renal or diabetes mellitus.
History taking, general examination, vital signs, thorough
chest and cardiac examination, and assessment of body mass
index (BMI): weight/height in meter square. Complete blood
picture, liver enzymes, total proteins and albumin, blood urea
and creatinine, and indirect haemagglutination test for schisto-
somal antibody. Plain chest X-ray was done for radiological
Table 1 Patients’ characteristics, spirometry, arterial blood
gasses and echocardiography’s.
Gender 7 males
3 females
Age(y) 43.70 ± 8.04.
BMI (kg/m2) 23.40 ± 3.66
FVC% of predicted 77.66 ± 20.20
FEV1/FVC 68.95 ± 9.84
FEF25–75% of predicted 54.84 ± 15.46
PH 7.43 ± 0.02
PaCO2 35.0 ± 3.30
PaO2 69.30 ± 13.61
SO2% 92.80 ± 3.2
Pulmonary acceleration time 65.70 ± 13.17
Mean pulmonary arterial pressure 50.44 ± 10.97
Right ventricular end-diastolic dimension (RVEDD) 3.26 ± 0.43
Left ventricular end-diastolic dimension (LVEDD) 4.01 ± 1.12
Left ventricular ejection fraction 64.70 ± 4.22
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tests (FVC, FEV1, FEV1/FVC, and EFE25–75%), and arterial
gazometry and acid base assessment were done.
Echocardiography was done and the following parameters
were measured: Pulmonary acceleration time (Act), Mean pul-
monary arterial pressure (mean PAP), PA systolic pressure,
Right ventricular dimention (RV-EDD), left ventricular end-
diastolic dimension (EDD), ratio between right and left ven-
tricular end-diastolic dimension (EDD), and left ventricular
ejection fraction (EF).
Epworth sleepiness scale (ESS): a simple self-administered
questionnaire which assess level of daytime sleepiness from
0–3 score the likelihood of falling asleep in eight various situ-
ations. ESS score 2–10 is considered ‘normal’ and >10 indic-
ative of pathological sleepiness.
Sleep study
All patients were subjected to sleep study where 8 of them
underwent using RESMED Apnea LinkTM System which mea-
sured the following cardiorespiratory data overnight [10].
(1) Absolute number of apneas and hypopneas.
(2) Apnea–hypopnea index (AHI).
(3) Absolute number of desaturations.
(4) Oxygen desaturation index (ODI).
(5) Pulse oximetry tracing with the average and lowest sat-
uration during the night.
(6) Snoring events.
(7) Flow limitation.
(8) Minimum, maximum, and average pulse frequency.
Two patients underwent full polysomnograpy which en-
abled us to determine the type of sleep apnea in them whether
obstructive or central.
Statistical analysis
Data were collected, tabulated, then analyzed using SPSS
ver.13. Qualitative data were presented as numbers and per-
centage. Quantitative data were expressed as mean and stan-
dard deviation. Comparisons of quantitative data between
two groups were tested by Student t-test. The Pearson correla-
tion coefﬁcient (r) was used to assess the relation between the
patients’ respiratory sleep parameters and numerical variables.
A 5% level was chosen as a level of signiﬁcance in all statistical
tests used in the study.
Results
Ten stable patients diagnosed with schistosomal pulmonary
hypertension (7 males and 3 females) and 10 healthy volunteers
matched for age, sex and BMI were enrolled in this study. Pa-
tients’ characteristics, spirometry, arterial blood gasses and
echocardiographic parameters in Table 1.
Sleepiness and respiratory sleep parameters
In the present study only four patients complained from exces-
sive daytime sleepiness (Epworth sleepiness scale score of
P10). (Table 2). Sleep apnea (SA) was present in the majorityof patients with schistosomal cor-pulmonale, as 80% of the pa-
tients were found to have an AHI > 10/h and 60% of the pa-
tients had moderate to severe sleep apnea (AHIP 15/h). We
have also demonstrated that sleep apnea in 2 patients (20%),
who had full polysomnographic recording, was of the obstruc-
tive type. In addition, the majority of the patients (80%) spent
>30% of the night with an arterial oxygen saturation <90%.
The respiratory sleep parameters of the patients are shown in
Table 2.
Also comparison of respiratory sleep parameters between
the patients and the control group revealed signiﬁcant differ-
ence in all parameters as shown in Table 3.
Correlation of the patients’ respiratory sleep parameters with
anthropometric, gazometric, spirometric, and echocardiographic
parameters
The patients’ respiratory sleep parameters were not correlated
with any of the anthropometric measures, arterial blood gasses
(ABG), spirometry or with the typical symptoms of sleep ap-
nea (SA) such as excessive sleepiness as assessed by the Ep-
worth sleepiness score.
However the mean pulmonary artery pressure was signiﬁ-
cantly correlated to the number of apneas, the oxygen desatu-
ration index, number of desaturations and the average oxygen
saturation (p= 0.05, 0.024 and 0.044 respectively) and that
the pulmonary acceleration time was signiﬁcantly correlated
to the number of hypopneas, number of desaturations and
the average oxygen saturation (p= 0.049, 0.043 and 0.047
respectively). Also, the RVEDD was signiﬁcantly correlated
to the number of desaturations (p= 0.045), (Table 4).
Patients’ subgrouping according to the sleep apnea severity
Patients were subdivided into two groups according to AHI at
a cut point of P15 events/h, group 1 included 4 patients with
mild SA (AHI < 15), group 2 included 6 patients with moder-
ate to severe SA (AHIP 15) and were compared as regards
the different parameters.
Table 3 Comparison of respiratory sleep parameters between
the patients and the control group.
Cases Control p
AHI 20.0 ± 11.34 2.30 ± 1.16 0.001*
ODI 14.0 ± 9.82 1.60 ± 1.07 0.003*
Saturation time 6 90% 55.10 ± 35.65 0.07 ± 1.06 0.001*
Average O2 saturation 86.50 ± 7.09 95.40 ± 1.51 0.003
*
Lowest O2 saturation 74.50 ± 12.69 91.0 ± 1.83 0.003
*
p:p value for Student t-test.
* Statistically signiﬁcant at p 6 0.05.
Table 2 Sleepiness and respiratory sleep parameters in the patients group.
Epworth sleepiness score AHI ODI Saturation time 6 90% Average O2 saturation Lowest O2 saturation
1 6 25 11 32% 91 86
2 4 6 5 10% 92 87
3 6 13 5 6% 92 86
4 10 34 31 100% 78 54
5 6 36 19 99% 75 62
6 6 16 15 75% 90 72
7 10 35 30 95% 76 60
8 12 13 11 41% 91 83
9 12 15 8 56% 90 86
10 4 9 5 37% 90 69
Mean ± SD 7.60 ± 3.10 20.0 ± 11.34 14.0 ± 9.82 55.1 ± 35.65 86.5 ± 7.09 74.5 ± 12.69
206 Y. Khalil et al.There was no signiﬁcant difference between the two sub-
groups as regards anthropometric measurements, ABG or
spirometry.
However, there was a signiﬁcant difference between the two
subgroups as regards the right ventricular end diastolic dimen-
sion (p= 0.010) as well as the left ventricular end diastolic
dimension (p= 0.036). Table 5, Fig. 1.
Discussion
This is the ﬁrst study investigating sleep- related breathing dis-
orders in patients with shistosomal pulmonary hypertension, a
progressive disease with limited survival. We found the AHI
was signiﬁcantly higher in patients with shistosomal pulmon-
ary hypertension than in the control group (p< 0.001). Also,Table 4 Correlation between echocardiographic and respiratory sle
Pulmonary acceleration time in m.sec
r p
AHI 0.560 0.092
No of apneas 0.609 0.061
No of hypopneas 0.634* 0.049
ODI 0.596 0.069
No of desaturations 0.647* 0.043
Saturation time 6 90% 0.478 0.163
Average O2 saturation 0.637
* 0.047
Lowest O2 saturation 0.393 0.261
r= Pearson correlation.
* Statistically signiﬁcant at p 6 0.05.sleep apnea (SA) was present in the majority of patients with
schistosomal cor-pulmonale, as 80% of the patients were
found to have an AHI > 10/h and 60% of the patients had
moderate to severe sleep apnea (AHIP 15/h). In addition,
the majority of the patients (80%) spent >30% of the night
with an arterial oxygen saturation <90%. Sleep-related
breathing disorders were not correlated with anthropometric
measures, arterial blood gasses, and spirometry nor with the
typical symptoms of SA such as excessive sleepiness as assessed
by the Epworth sleepiness score. This is in accordance with
earlier observations that patients with left ventricular failure
and CSR/CSA did not feel particularly sleepy [9].
Cheyne–Stokes respiration (CSR) is a speciﬁc form of cen-
tral sleep apnea (CSA) that can be observed in patients with
congestive heart failure (CHF). Among other factors, prolon-
gation of circulation time, hypocapnia and hypoxia are
thought to underlie this sleep-related breathing disorder [11].
In advanced shistosomal PH profound abnormalities in the
hemodynamics and gas exchange parameters may be found.
Due to the increased pulmonary artery pressure and pulmon-
ary vascular resistance, cardiac output is likely to be depressed.
Together with ventilation-perfusion mismatching this low out-
put syndrome leads to hypoxemia [12]. Finally, to compensate
for hypoxemia, hyperventilation and consequent hypocapnia
develops, as is found in 5 patients (50%) in our studied group.
Thus, the same basic mechanisms presumed to underlie CSR
and CSA in CHF might apply in BPH.
Bilharzial corpulmonale patients who are hypocapnic dur-
ing wakefulness can develop apnea at sleep onset due to lossep parameters.
Mean pulmonary artery pressure RVEDD
r p r p
0.567 0.087 0.563 0.090
0.633* 0.049 0.507 0.135
0.593 0.071 0.322 0.365
0.632* 0.049 0.401 0.251
0.702* 0.024 0.643* 0.045
0.485 0.155 0.541 0.106
0.646* 0.044 0.440 0.203
0.426 0.219 0.167 0.645
Table 5 Comparison between the patients’ subgroups according to echo parameters.
Group 1 mild SA AHI < 15 Group 2 Moderate-severe SA AHIP 15 p
Pulmonary acceleration time in m.sec 69.25 ± 10.69 63.33 ± 15.06 0.591
Mean pulmonary artery pressure 69.0 ± 2.58 68.50 ± 6.66 0.891
RVEDD (<2.6) 3.02 ± 0.52 4.67 ± 0.88 0.010*
LVEDD (<5.8) 2.93 ± 0.32 3.49 ± 0.36 0.036*
p:p value for Student t-test.
* Statistically signiﬁcant at p 6 0.05.
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
RVEDD (<2.6) LVEDD (<5.8)
M
ea
n
Group I
Group II
Figure 1 Comparison between the patients sub groups according
to RVEDD.
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Recent work has focused on ventilatory instability at the tran-
sition between wakefulness and sleep. It appears that the ap-
neic threshold exists only slightly below measured PaCO2
during drowsiness but before sleep onset. A variety of factors
can narrow the difference between the apneic threshold and
PaCO2 during this transition (CO2 reserve) and lead to an
unstable breathing pattern. These include conditions that in-
crease ventilatory responsiveness to CO2 in the domain be-
tween the apneic threshold and eupnea, including hypoxia or
pulmonary vascular engorgement with circulatory delay,
which are present in patients with bilharzial corpulmonale [13].
We have also demonstrated that sleep apnea in 2 patients
(20%) was of the obstructive type suggesting that OSA does
in fact exist in some bilharzial corpulmonale patients. Since
there was no correlation between the SRBD parameters and
the BMI we can suggest that the underlying mechanism of this
OSA is related to an intrinsic process of the underlying disease
and not to obesity especially that the studied patients were on
average not obese (23.4 ± 3.66). Studies on patients with HF
and proven SDB indicates that, during sleep, ﬂuid from the
lower extremities shifts to the neck region of the body, causing
mechanical constraints in the upper airway which worsens
their SDB [14]. Although it is well known that ventilatory
instability is an important risk factor for central sleep apnea
and Cheyne–Stokes respiration, recent data indicate that it is
also a risk factor for severe obstructive sleep apnea. Also other
mechanisms responsible for obstructive sleep apnea in schisto-
somal cor-pulmonale patients may include defects in thecontrol of breathing, respiratory muscle dysfunction, [15]
and abnormalities in chest wall and lung compliance. It has
been proposed that the central control of breathing in these pa-
tients with abnormal lung mechanics, and weakened respira-
tory muscles, may affect the ventilatory response to hypoxia
and hypercapnia and cause upper airway collapse [8,16].
Similar to our results Ulrich et al., who investigated the
prevalence and type of sleep-related breathing disturbances
in patients with different forms of PH, found that even though
CSR/CSA was common in their studied group, obstructive
sleep apnea was also present [9]. Also, Krishnan et al. in a ret-
rospective review of patients with pulmonary hypertension
who were referred for polysomnography found the prevalence
of SDB to be 82.6% in this population [8].
Sleep-related hypoxemia syndrome is deﬁned as ‘‘an arterial
oxygen saturation (Spo2) during sleep of <90% for more than
ﬁve minutes with a nadir of at least 85% or >30% of total
sleep time with a SpO2 of <90% [13]. We found that sleep-in-
duced hypoxemia is very common in patients with shist PAH,
as the majority of the patients (80%) spent >30% of the night
with an arterial oxygen saturation <90%. Multiple mecha-
nisms may contribute to nocturnal hypoxia, including altera-
tions in ventilation perfusion ratio, reduced functional
residual capacity, reduced respiratory drive, alveolar hypoven-
tilation and upper airway obstruction. These mechanisms take
on added importance in patients with preexisting pulmonary
disease [17].
The exact mechanism for nocturnal hypoxia in PAH pa-
tients remains elusive. In bilharzial cor-pulmonale; nocturnal
hypoxemia alone may be related to day time hypoxemia with
the product of worsening ventilation/perfusion mismatch with
greater effective shunt. This is further supported by our ﬁnding
of a positive correlation of the awake O2 saturation with the
average and the lowest O2 saturation during sleep (p= 0.014
and p= 0.004 respectively). Comparable to our results Ay-
dogdu et al. in have conﬁrmed severe oxygen desaturations
during sleep in cases of ILD and there was a signiﬁcant posi-
tive correlation between mean awake O2 saturation and mean
and lowest sleep O2 saturations [18]. Furthermore, nocturnal
hypoxemia may be due to the presence of underlying SAHS
as detected in the present study. As we have found that pa-
tients with moderate to severe SA had signiﬁcantly higher sat-
uration time <90% (p= 0.033) than patients with mild SA.
A very important ﬁnding in the study is that the SRBD
found in our bilharzial corpulmonale patients was signiﬁcantly
associated with measures of pulmonary hypertension severity.
As we have found that the mean pulmonary artery pressure
was signiﬁcantly correlated to the number of apneas, the
oxygen desaturation index and the average oxygen saturation
(p= 0.05, 0.024 and 0.044 respectively) and that the
208 Y. Khalil et al.pulmonary acceleration time was signiﬁcantly correlated to the
number of hypopneas (p= 0.049). Also, a comparison of
hemodynamic variables in our studied group according to their
AHI at a cut point of 15 further conﬁrmed the fact that
patients with moderate to severe SA had more impaired car-
diovascular function as indicated by more severe right ventric-
ular dilatation (p= 0.036) than patients with mild sleep apnea.
Also despite of the presence of normal LVEDD in all the pa-
tients, those with moderate to severe SA had higher LVEDD
(p= 0.010) in comparison to the mild group.
Therefore, sleep-related breathing disorders in our studied
group are correlated with more advanced pulmonary hyperten-
sion and more severe hemodynamic impairment. And since
CSR/CSA in patients with left ventricular failure has been
associated with severe hemodynamic impairment, hypocapnia,
increased sympathetic tone, and impaired prognosis [9]. We
can hypothesize that similar mechanisms may also predispose
patients with right-heart failure associated with PH to CSR/
CSA and unfavorably inﬂuence their well-being. Since the
reduction of cardiac performance is associated with prolonga-
tion of the circulation time which causes delayed transmission
of changes in arterial blood gasses to the central and peripheral
chemoreceptors which would cause ventilatory undershooting
and overshooting and a periodic breathing pattern of the cen-
tral or Cheyne–Stokes type [12,19]. Therefore this signiﬁcant
association between sleep apnea and the severity of cardiovas-
cular impairment further supports this explanation.
Apart from being a consequence of bilharzial corpulmo-
nale, SRBD might as well contribute to worsening of PH as
the apnea associated hypoxia could trigger further vasocon-
striction of pulmonary vessels. Thus, SA in SPH might not
only constitute an adverse prognostic sign, as is known for
CSR in CHF, but it may also contribute to the further progres-
sion of the disease [12,20]. Larger studies are required to inves-
tigate the implications of chronic hypoxia in PAH, and to
clarify the potential beneﬁts of treating nocturnal hypoxia with
long-term oxygen supplementation.
Conclusion
From our study we can conclude that SRB disorders as sleep
apnea either obstructive or central or even mixed and noctur-
nal desaturation are highly prevalent in patients with schisto-
somal cor-pulmonale. Among our group of patients, the SA
severity was correlated with more advanced PH and more se-
vere cardiovascular impairment. Therefore in the evaluation
of patients with PAH, polysomnography or an ambulatory
cardiorespiratory sleep study seems justiﬁed to identify poten-
tially treatable SRBD that may additionally challenge the al-
ready compromised cardiovascular system in these patients.
Moreover, larger studies are required to investigate the clinical
and prognostic implications of SRBD in shistosomal pulmon-
ary hypertension and to evaluate different treatment
modalities for these disorders such as supplemental oxygen
or CPAP, which may provide therapeutic beneﬁts thatcomplement standard pharmacologic therapy for shistosomal
pulmonary hypertension and corpulmonale.
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